Instead, other reports show that ALOX5 may have opposite roles in a different context that it promoted BCR-ABL driven B-cell acute lymphoblastic leukemia while inhibited MLL-fusion driven acute myeloid leukemia [11, 31]. The gene discussed is BCR; the disease is B-cell acute lymphoblastic leukemia.